Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 4, 2011, Pages 731-741

  Floeth, Frank Willi ^a   Sabel, Michael ^a   Ewelt, Christian ^b   Stummer, Walter ^b   Felsberg, Jörg ^a   Reifenberger, Guido ^a   Steiger, Hans Jakob ^a   Stoffels, Gabriele ^c   Coenen, Heinz Hubert ^c   Langen, Karl Josef ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

5 Aminolevulinic acid (5 ALA); 18F Fluoroethyl L tyrosine (18F FET); Amino acid PET; Cerebral glioma; Fluorescence guided resection; Gd DTPA enhancement

Indexed keywords

AMINOLEVULINIC ACID; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; FLUOROETHYLTYROSINE F 18; GADOLINIUM PENTETATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; FLUORESCENCE; GLIOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; TUMOR BIOPSY;

ADULT; AGED; AMINOLEVULINIC ACID; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; FEMALE; GADOLINIUM DTPA; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SPECTROMETRY, FLUORESCENCE; TYROSINE;

EID: 79953725702     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1690-z     Document Type: Article

References (24)

1. Stummer W, Tonn JC, Mehdorn HM, Nestler U, Franz K, Goetz C, et al. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. J Neurosurg Epub, 2010 Apr 16. doi: 10.3171/2010.3. JNS097
2. TN Byrne 1994 Imaging of gliomas Semin Oncol 21 162 167 8153662 1:STN:280:DyaK2c3gsVKrsg%3D%3D
3. EP Jansen LG Dewit M van Herk H Bartelink 2000 Target volumes in radiotherapy for high-grade malignant glioma of the brain Radiother Oncol 56 151 156 10927133 10.1016/S0167-8140(00)00216-4 1:STN:280:DC%2BD3M%2Fit1yisQ%3D%3D (Pubitemid 30601671)
4. M Watanabe R Tanaka N Takeda 1992 Magnetic resonance imaging and histopathology of cerebral gliomas Neuroradiology 34 463 469 1436452 10.1007/BF00598951 1:STN:280:DyaK3s%2FmtlOqtw%3D%3D
5. D Kondziolka LD Lunsford AJ Martinez 1993 Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma J Neurosurg 79 533 536 8410222 10.3171/jns.1993.79.4.0533 1:STN:280:DyaK2c%2FhsFemtw%3D%3D (Pubitemid 23289810)
6. PL Jager W Vaalburg J Pruim EG de Vries KJ Langen DA Piers 2001 Radiolabeled amino acids: basic aspects and clinical applications in oncology J Nucl Med 42 432 445 11337520 1:CAS:528:DC%2BD3MXmvFOqt7k%3D (Pubitemid 32207394)
7. T Singhal TK Narayanan V Jain J Mukherjee J Mantil 2008 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas Mol Imaging Biol 10 1 18 17957408 10.1007/s11307-007-0115-2
8. HJ Wester M Herz W Weber P Heiss R Senekowitsch-Schmidtke M Schwaiger, et al. 1999 Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging J Nucl Med 40 205 212 9935078 1:CAS:528:DyaK1MXos1aitA%3D%3D (Pubitemid 29044193)
9. K Hamacher HH Coenen 2002 Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine Appl Radiat Isot 57 853 856 12406628 10.1016/S0969-8043(02)00225-7 1:CAS:528:DC%2BD38Xot1entrc%3D (Pubitemid 35284220)
10. KJ Langen K Hamacher M Weckesser F Floeth G Stoffels D Bauer, et al. 2006 O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications Nucl Med Biol 33 287 294 16631076 10.1016/j.nucmedbio.2006.01.002 1:CAS:528:DC%2BD28Xjs1GksLw%3D
11. D Pauleit F Floeth K Hamacher MJ Riemenschneider G Reifenberger HW Müller, et al. 2005 O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas Brain 128 678 687 15689365 10.1093/brain/awh399 (Pubitemid 40380202)
12. D Pauleit G Stoffels A Bachofner FW Floeth M Sabel H Herzog, et al. 2009 Comparison of (18)F-FET and (18)F-FDG PET in brain tumors Nucl Med Biol 36 779 787 19720290 10.1016/j.nucmedbio.2009.05.005 1:CAS:528:DC%2BD1MXhtVKrsLfJ
13. G Pöpperl C Götz W Rachinger FJ Gildehaus JC Tonn K Tatsch 2004 Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma Eur J Nucl Med Mol Imaging 31 1464 1470 15248032 10.1007/s00259-004-1590- 1 (Pubitemid 39592765)
14. JC Tonn W Stummer 2008 Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls Clin Neurosurg 55 20 26 19248665 Review
15. W Stummer A Novotny H Stepp C Goetz K Bise HJ Reulen 2000 Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients J Neurosurg 93 1003 1013 11117842 10.3171/jns.2000.93.6.1003 1:CAS:528:DC%2BD3cXptValsro%3D (Pubitemid 32800611)
16. W Stummer U Pichlmeier T Meinel OD Wiestler F Zanella HJ Reulen, et al. 2006 ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Lancet Oncol 7 392 401 16648043 10.1016/S1470-2045(06)70665-9 1:CAS:528:DC%2BD28XjvFWlsb0%3D
17. G Widhalm S Wolfsberger G Minchev A Woehrer M Krssak T Czech, et al. 2010 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement Cancer 116 1545 1552 20108311 10.1002/cncr.24903 1:CAS:528:DC%2BC3cXktFGgsLY%3D
18. F Stockhammer M Misch P Horn A Koch N Fonyuy M Plotkin 2009 Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas Acta Neurochir (Wien) 151 1377 1383 10.1007/s00701-009- 0462-7
19. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. World Health Organization classification of tumours of the central nervous system. Lyon: IARC Press; 2007. p. 25-68.
20. M Lacroix D Abi-Said DR Fourney ZL Gokasian W Shi F DeMonte, et al. 2001 A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival J Neurosurg 95 190 198 11780887 10.3171/jns.2001.95.2.0190 1:STN:280:DC%2BD38%2FlsFGitA%3D%3D (Pubitemid 32799739)
21. U Pichlmeier A Bink G Schackert W Stummer ALA Glioma Study Group 2008 Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients Neuro Oncol 10 1025 1034 18667747 10.1215/15228517-2008-052
22. AL Grosu U Nestle WA Weber 2009 How to use functional imaging information for radiotherapy planning Eur J Cancer 45 Suppl 1 461 463 19775672 10.1016/S0959-8049(09)70090-5
23. BJ Pirotte M Levivier S Goldman N Massager D Wikler O Dewitte, et al. 2009 Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients Neurosurgery 64 471 481 19240609 10.1227/01.NEU.0000338949.94496.85
24. G Pöpperl FW Kreth JH Mehrkens J Herms K Seelos W Koch, et al. 2007 FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading Eur J Nucl Med Mol Imaging 34 1933 1942 17763848 10.1007/s00259-007-0534-y (Pubitemid 350212135)